PharmaCorp Rx Inc. Completes Acquisition of a Pharmacy in Western Canada
August 7, 2025
PharmaCorp Rx Inc. (TSXV: PCRX) completed the purchase of a 100% interest in an independent pharmacy located in Western Canada for CAD 2,400,000, funded with cash on hand. The deal is the company's fourth completed pharmacy acquisition and is being executed in conjunction with its strategic alliance with PharmaChoice Canada to grow PharmaCorp's network of bannered community pharmacies.
- Buyers
- PharmaCorp Rx Inc.
- Targets
- Acquired Pharmacy (Western Canada)
- Industry
- Healthcare Services
- Location
- Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
PharmaCorp Rx Inc. Acquires Pharmacy in Atlantic Canada
October 2, 2024
Healthcare Services
PharmaCorp Rx Inc. (TSXV: PCRX) completed the acquisition of a 100% interest in a pharmacy business, including the associated land and buildings, located in Atlantic Canada for an aggregate purchase price of $15,377,013. The transaction was financed with $15,177,013 in cash and $200,000 in common shares and expands PharmaCorp’s roll-up of independent PharmaChoice Canada-affiliated pharmacies.
-
CareRx Acquires Hogan Pharmacy Partners Ltd.
March 30, 2022
Healthcare Services
CareRx Corporation entered into a definitive asset purchase agreement to acquire Hogan Pharmacy Partners Ltd., a technology-enabled long-term care pharmacy serving about 725 residents in Ontario. The consideration includes C$2.2 million in CareRx common shares and a C$2.2 million vendor take-back note; CareRx expects the deal to close in May 2022 and to be immediately accretive to earnings while extending its technology and service capabilities for seniors' congregate care.
-
Mednow Inc. Acquires Mednow Pharmacy Inc. (Mednow West)
October 26, 2021
Healthcare Services
Mednow Inc. completed the acquisition of all issued and outstanding shares of Mednow Pharmacy Inc. ("Mednow West"), consolidating the British Columbia online pharmacy into its national virtual-pharmacy platform. The purchase involved an aggregate cash payment of approximately $74,000 and conversion of about $908,000 owed by Mednow West into a convertible promissory note; the move supports Mednow's geographic expansion across Canada.
-
Neighbourly Pharmacy Acquires Rubicon Pharmacies for $435M
March 10, 2022
Healthcare Services
Neighbourly Pharmacy Inc. agreed to acquire Rubicon Pharmacies for CAD $435 million, adding 100 retail pharmacy locations and more than 1,500 employees. The deal, which materially increases Neighbourly's pro‑forma revenues and EBITDA, will be partially financed via a CAD $130 million public subscription receipt offering and a CAD $120 million private placement by Persistence Capital Partners (Neighbourly's largest shareholder).
-
ProPharma Group Acquires Pharmica Consulting
October 6, 2021
Healthcare Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.
-
Mednow Inc. Acquires Mednow Pharmacy Inc. (Mednow East)
April 1, 2022
Healthcare Services
Mednow Inc. (TSXV:MNOW) has completed the previously announced acquisition of all issued and outstanding voting shares of Mednow Pharmacy Inc. ("Mednow East") for approximately C$65,578 in cash and by converting approximately C$1,374,422 of intercompany debt into a non‑interest bearing convertible promissory note. Mednow East will be consolidated into Mednow's operations, the existing pharmacy agreement between the entities will be terminated, and the acquisition supports Mednow’s plan to expand its national presence and digital-first pharmacy services across Canada.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.